Heart Transplant Rejection Breath Test Data Falls Short – CMS
This article was originally published in The Gray Sheet
Executive Summary
Medicare coverage of a breathalyzer test to detect heart transplant rejection is not warranted based on the current level of supporting data, CMS says
You may also be interested in...
It’s Final: No Medicare Coverage For Heart Transplant Rejection Test
Medicare will not cover Menssana Research's Heartsbreath heart transplant rejection test, CMS said Dec. 8
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.